Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Retained Earnings (2018 - 2025)

Neurogene's Retained Earnings history spans 6 years, with the latest figure at -$352.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 34.43% year-over-year to -$352.6 million; the TTM value through Dec 2025 reached -$352.6 million, down 34.43%, while the annual FY2025 figure was -$352.6 million, 34.43% down from the prior year.
  • Retained Earnings reached -$352.6 million in Q4 2025 per NGNE's latest filing, down from -$327.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$13000.0 in Q2 2023 to a low of -$465.3 million in Q1 2023.
  • Average Retained Earnings over 3 years is -$259.7 million, with a median of -$262.3 million recorded in 2024.
  • The largest YoY upside for Retained Earnings was 56.13% in 2024 against a maximum downside of 1712207.69% in 2024.
  • A 3-year view of Retained Earnings shows it stood at -$187.2 million in 2023, then plummeted by 40.15% to -$262.3 million in 2024, then crashed by 34.43% to -$352.6 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Retained Earnings are -$352.6 million (Q4 2025), -$327.9 million (Q3 2025), and -$307.0 million (Q2 2025).